Philip Hawke

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
This study compares the safety profiles of pegylated interferon (PEG-IFN) α-2a and α-2b administered in combination with ribavirin, based on the variable of time to withdrawal from treatment due to(More)
  • 1